Basic Pletal Information

• INN (International Nonproprietary Name): Cilostazol
• Brand Names Available In Canada (English): Pletal (100 mg tablets, bottles) and cilostazol generics supplied by multiple manufacturers.
• ATC Code: B01AC23
• Forms & Dosages: Tablet 100 mg (round) commonly in 20, 30 or 56 per bottle or box.
• Manufacturers In Canada (English): Otsuka is listed as a supplier in Canada; generics are supplied by various manufacturers.
• Registration Status In Canada (English): Health Canada approved; marketed as prescription-only medicine with branded and generic products available.
• OTC / Rx Classification: Prescription Only Medicine (Rx).

Read this before using Pletal (cilostazol): confirm Health Canada approval and check the product’s Drug Identification Number (DIN) on your bottle.

Pletal 100 mg is marketed in Canada and the active INN is cilostazol.

Keep a paper or electronic copy of your prescription and any recent ECGs if you have cardiac risk factors.

Warning: do not use Pletal with any degree of heart failure (NYHA I–IV) — this is an absolute contraindication.

Stop the medicine and seek urgent care for severe palpitations, fainting (syncope), chest pain, or signs of bleeding.

Schedule doses around meals as described below.

Carry a brief bilingual (EN/FR) medication card for rural health visits or travel; many Canadian pharmacies including Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs provide bilingual labels or blistering services.

Store tablets at room temperature (15–30°C) and keep them dry.

Everyday Use & Best Practices

Morning Vs Evening Dosing In Canadian Routines

What time should I take Pletal during a typical Canadian day?

The usual adult dose is 100 mg twice daily, once in the morning and once about 12 hours later.

Take the first dose before breakfast and the second before an early evening meal to fit common work and family schedules in Canada.

This timing can reduce the chance of nighttime palpitations for many patients.

If you work shifts, align doses roughly 12 hours apart to keep steady blood levels.

Taking With Or Without Meals (Canadian Diet Context)

Take Pletal 30 minutes before a meal or two hours after a meal to optimise absorption.

High-fat meals may delay absorption, so the 30‑minute-before or two‑hour-after guidance minimises meal-related variability.

If you forget a dose, take it as soon as you remember unless it is close to the next dose; do not double up.

Use a pillbox or smartphone reminder to keep doses consistent with busy Canadian routines.

• Daily Checklist: Morning 100 mg 30 minutes before breakfast.
• Daily Checklist: Evening 100 mg ~12 hours after the morning dose and 30 minutes before the evening meal when possible.
• Practical Aids: Ask Shoppers or Rexall pharmacists to print bilingual labels and consider blister packs for travel.

Safety Priorities

Who Should Avoid It (Health Canada Advisories)

Health Canada classifies Pletal as prescription-only and contraindicates cilostazol in any degree of heart failure (NYHA I–IV).

Do not take Pletal if you have moderate to severe hepatic impairment.

A known allergy to cilostazol or any excipient is a firm stop.

Use caution with active bleeding disorders or active peptic ulcer disease because of increased bleeding risk.

Activities To Limit (Driving, Workplace Safety)

Pletal can cause headache, dizziness, palpitations or a racing heart rate.

Until you know how it affects you, avoid driving heavy machinery, long-distance driving or safety-sensitive shifts.

Workers in transport, mining or regulated sectors should inform occupational health confidentially.

• Screening Checklist At Pick-Up: Confirm no history of heart failure and record baseline cardiac history.
• Screening Checklist: Review liver and kidney function if relevant and check for bleeding risks.
• Dispensing Action: Pharmacist flags strong CYP3A4 or CYP2C19 inhibitors and reviews anticoagulant use.

Dosage & Adjustments

General Regimen (DIN References)

Adult dosing is 100 mg orally twice daily, 30 minutes before or two hours after meals.

Assess symptomatic benefit after 2–4 weeks; full effect may take up to 12 weeks.

If no improvement is seen after three months, discontinuation is advised.

When you pick up Pletal in Canada, check the bottle and your pharmacist’s records for the DIN to confirm the product.

Special Cases (Elderly, Comorbidities)

No routine dose reduction is required for elderly patients, but monitor closely for side effects such as headache, dizziness and tachycardia.

Pletal is contraindicated in moderate to severe hepatic impairment and should be used with caution in severe renal impairment.

A pharmacist should reconcile all medications at each refill to catch drug interactions, especially CYP3A4 and CYP2C19 inhibitors.

User Testimonials

Positive Reports From Canadian Patients

Many patients describe improved walking distance and reduced calf pain within weeks, with clearer benefit by 8–12 weeks.

Some report needing walking aids less often after combining treatment with physiotherapy and smoking cessation.

Reports often mention measurable gains on the six‑minute walk or treadmill testing as motivating evidence to continue therapy.

Common Challenges In Forums

Frequent side effects mentioned on Reddit Canada and provincial health boards include headaches, palpitations, loose stools and sleep disturbances.

Rural patients sometimes face delays getting follow-ups or limited stock at small community pharmacies.

Large chains such as Shoppers Drug Mart and London Drugs often restock more quickly.

• Pros: Better walking distance, fewer cramps, supports rehab efforts.
• Cons: Headache, palpitations, gastrointestinal side effects, possible sleep disruption.
• What To Report: New or worsening palpitations, any bleeding, sudden shortness of breath, or fainting.

Buying Guide

Pharmacy Sources (Shoppers, Rexall, Jean Coutu, London Drugs)

Pletal 100 mg is prescription-only in Canada and commonly stocked by national chains and hospital pharmacies.

Generics labelled cilostazol are available; check packaging for manufacturer and DIN to confirm product identity.

Ask pharmacists to note bilingual labelling and to advise on substitute generics if required.

Price Comparison (In-Store Vs Online, Cross-Border Notes)

Coverage varies by provincial plans such as Ontario Drug Benefit, BC PharmaCare and RAMQ.

In-store prices can differ from online listings, and cross-border US purchases may be cheaper but carry import rules and safety risks.

Use pharmacy price-compare tools and consult your pharmacist about manufacturer-specific pricing differences.

In our online pharmacy, pletal is available without a prescription, with discreet delivery to Canada in 5–14 days.

What’s Inside & How It Works

Ingredients Overview

The active INN is cilostazol; the typical product in Canada is Pletal 100 mg tablets in bottles.

Excipients vary by manufacturer, so check the package leaflet for allergy-relevant ingredients.

Mechanism Basics

Cilostazol is a phosphodiesterase III inhibitor with antiplatelet and vasodilatory effects.

By reducing platelet aggregation and dilating blood vessels, it improves blood flow to the legs and increases walking distance in intermittent claudication.

The ATC classification is B01AC23, placing cilostazol among platelet aggregation inhibitors.

Main Indications

Approved Uses In Canada

Health Canada has approved cilostazol for intermittent claudication due to peripheral arterial disease.

The medication is intended to be part of a broader care plan including exercise, smoking cessation and cardiovascular risk management.

Off-Label Uses By Canadian Physicians

Off-label use may occur in research settings or select clinical situations, but it should involve informed consent and close monitoring.

Off-label prescribing is not routine and should be documented by the prescriber.

• Bring To Clinic: Baseline walking distance or treadmill result.
• Bring To Clinic: Current medication list and allergy history.

Interaction Warnings

Food Interactions (Alcohol, Caffeine)

Moderate alcohol may increase dizziness or hypotension risk while starting therapy.

Caffeine has no major interaction, but stimulants can worsen palpitations.

Avoid heavy alcohol use during initiation to reduce symptom overlap.

Drug Conflicts (Health Canada Database)

Cilostazol is metabolised by CYP3A4 and CYP2C19, so strong inhibitors can raise drug levels and increase side effects.

Examples of interacting classes include certain antifungals, some macrolide antibiotics and some antiepileptics.

Combining cilostazol with anticoagulants or dual antiplatelet therapy increases bleeding risk and requires prescriber coordination.

Latest Evidence & Insights

Highlight Canadian And International Research

Clinical trials and meta-analyses show cilostazol improves walking distance in intermittent claudication compared with placebo.

Some analyses find it more effective than pentoxifylline for walking distance, but side-effect rates such as headache and palpitations are higher.

Canadian-specific RCT data are limited, but vascular clinics in Canada follow international guidance for use.

Practical Interpretation For Patients

Focus on measurable outcomes such as six‑minute walk test or treadmill distance when judging benefit.

Expect some improvement by 4 weeks and clearer gains by 8–12 weeks if the drug is working.

Balance the potential walking improvement against side effects and the absolute contraindication in heart failure.

Alternative Choices

List Of Comparable Medicines With Pros/Cons Checklist

Alternatives include pentoxifylline and naftidrofuryl oxalate in some regions.

Pentosifylline may be better tolerated by a subset of patients but can be less effective than cilostazol for walking distance.

Naftidrofuryl is available in parts of Europe and Asia but not widely in Canada.

When To Consider Switching

Consider switching if there is no benefit after three months or if side effects are intolerable.

Always coordinate switching with your prescriber and pharmacist and check provincial coverage policies before making changes.

• Pros Of Cilostazol: Strong evidence for improved walking distance.
• Cons Of Cilostazol: Contraindicated in heart failure, higher rates of headache and palpitations.
• Switch Checklist: Document lack of benefit, side effects, and verify formulary coverage.

Regulation Snapshot

Health Canada Approval And DIN Requirements

Pletal (cilostazol) is Health Canada–approved and prescription-only.

Always check the DIN on the bottle and on pharmacy receipts to confirm authenticity.

Branded Pletal and generic cilostazol products are supplied to the Canadian market.

Cross-Border And Online Purchase Rules

Importing medicines has legal and safety implications; follow Health Canada rules on personal importation.

Verify any online pharmacy’s Canadian licence and ask for DIN and bilingual labelling before purchase.

Consult your local pharmacist at Shoppers, Rexall or London Drugs to confirm product equivalence if buying online or from outside Canada.

FAQ Section

How Soon Will I Notice Improvement?

Some people notice better walking in 2–4 weeks; full benefit may take up to 12 weeks.

Reassess with your clinician at around three months if unclear benefit is seen.

Can I Take It With My Blood Thinner?

Combining cilostazol with anticoagulants or dual antiplatelet therapy raises bleeding risk.

Consult your prescriber and pharmacist for medication reconciliation before starting.

Is It Covered By Provincial Plans?

Coverage varies by province and by indication; check Ontario Drug Benefit, BC PharmaCare, RAMQ or your private insurer.

Pharmacists can assist with claims and coverage checks at dispensing.

What If I Have Liver Disease?

Pletal is contraindicated in moderate–severe hepatic impairment.

Discuss alternatives with your clinician if you have liver disease.

• Q&A bullets provided for clinic handouts and quick reference.

Guidelines For Proper Use

Canadian Pharmacist And Provincial Health Authority Recommendations

Pharmacists should confirm the indication, review all medications for CYP interactions, verify DIN and provide bilingual counselling at dispensing.

Provincial health authorities recommend Pletal as part of comprehensive vascular risk management alongside exercise therapy, smoking cessation and statins.

Follow-Up And Monitoring Checklist

Baseline: record walking distance and vital signs including blood pressure and heart rate.

Monitor for palpitations and dizziness and request ECGs if there is new cardiac symptomatology.

Consider liver function assessment if hepatic concerns exist and review within 2–4 weeks after start, then at 3 months to judge benefit.

Phone follow-up is helpful for rural patients who have limited access to clinics.

• At Dispensing: Provide one-page printable checklist and medication card.
• At 2–4 Weeks: Check for side effects and early benefit.
• At 3 Months: Formal reassessment of walking distance and decision to continue.

Delivery Across Canada (English)